30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Medimmune LLC (MEDI)

Track

Stock chart
Ticker: MEDI Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
ZOTH LOTA S
Senior Vice President & CFO
2 sales — total 46,206 USD
Sale 13 Feb 2007
Value US$3,391,335.45 | Price 340.85 | Shares 86,795
Sale 13 Feb 2007
Value US$4,521,722.79 | Price 75.28 | Shares 47,291
Sale 8 Feb 2007
Value US$717,865.67 | Price 289.33 | Shares 37,570
Sale 8 Feb 2006
Value US$400,954.80 | Price 33.41 | Shares 12,000
Sale 7 Feb 2006
Value US$1,347,052.00 | Price 33.68 | Shares 40,000
Sale 3 Feb 2006
Value US$1,303,420.00 | Price 32.59 | Shares 40,000
Sale 3 Feb 2006
Value US$235,374.25 | Price 32.75 | Shares 7,187
Sale 3 Feb 2006
Value US$142,625.00 | Price 32.60 | Shares 4,375
Sale 3 Feb 2006
Value US$281,863.58 | Price 32.62 | Shares 8,640
Sale 14 Nov 2005
Value US$1,485,162.00 | Price 35.36 | Shares 42,000
Sale 8 Nov 2005
Value US$1,417,836.88 | Price 34.90 | Shares 40,625
Sale 21 Oct 2005
Value US$68,216.20 | Price 34.11 | Shares 2,000
Sale 21 Oct 2005
Value US$2,339,036.00 | Price 33.41 | Shares 70,000
Sale 3 Mar 2005
Value US$725,076.00 | Price 24.17 | Shares 30,000
Planned sale 7 Feb 2005
Value US$2,431,290.00 | Price 24.31 | Shares 100,000
Sale 30 Jul 2004
Value US$922,836.00 | Price 23.07 | Shares 40,000
Sale 6 May 2004
Value US$2,547,436.50 | Price 24.26 | Shares 105,000
Sale 28 Apr 2004
Value US$11,101,401.29 | Price 25.71 | Shares 431,820
Sale 28 Apr 2004
Value US$465,408.00 | Price 25.60 | Shares 18,180
Planned sale 5 Feb 2004
Value US$1,721,292.63 | Price 24.59 | Shares 69,996
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2007-02-15 2007-02-13 S Sale ZOTH LOTA S

Senior Vice President & CFO

Officer
86,795 +11.6%
340.85
US$3,391,335 		86,795 +11.6% 340.85 US$3,391,335
2007-02-15 2007-02-13 S Sale ZOTH LOTA S

Senior Vice President & CFO

Officer
47,291 +14.1%
75.28
US$4,521,723 		47,291 +14.1% 75.28 US$4,521,723
2007-02-12 2007-02-08 S Sale CONNOR EDWARD M

Executive Vice President, CMO

Officer
37,570 +42.1%
289.33
US$717,866 		37,570 +42.1% 289.33 US$717,866
2006-02-09 2006-02-08 S Sale Kiener Peter A

SVP, Research

Officer
12,000 -100.0%
33.41
US$400,955 		12,000 -100.0% 33.41 US$400,955
2006-02-09 2006-02-07 S Sale HACKMAN FRANKLIN BARBARA Non-Executive Director
40,000 -89.0%
33.68
US$1,347,052 		40,000 -89.0% 33.68 US$1,347,052
2006-02-07 2006-02-03 S Sale Mathers Edward T

SVP, Corporate Dev.

Officer
40,000 -100.0%
32.59
US$1,303,420 		40,000 -100.0% 32.59 US$1,303,420
2006-02-07 2006-02-03 S Sale ANIDO ARMANDO

EVP, Sales and Mktg

Officer
7,187 -83.0%
32.75
US$235,374 		7,187 -83.0% 32.75 US$235,374
2006-02-07 2006-02-03 S Sale ANIDO ARMANDO

EVP, Sales and Mktg

Officer
4,375 -33.6%
32.60
US$142,625 		4,375 -33.6% 32.60 US$142,625
2006-02-07 2006-02-03 S Sale YOUNG JAMES F

President, R&D

Officer
8,640 -50.0%
32.62
US$281,864 		8,640 -50.0% 32.62 US$281,864
2005-11-16 2005-11-14 S Sale Folena-Wasserman Gail M

SVP, Development

Officer
42,000 -100.0%
35.36
US$1,485,162 		42,000 -100.0% 35.36 US$1,485,162
2005-11-09 2005-11-08 S Sale ANIDO ARMANDO

EVP, Sales & Marketing

Officer
40,625 -96.5%
34.90
US$1,417,837 		40,625 -96.5% 34.90 US$1,417,837
2005-10-25 2005-10-21 S Sale Machielse Bernardus N M

SVP, Operations

Officer
2,000 -34.4%
34.11
US$68,216 		2,000 -34.4% 34.11 US$68,216
2005-10-25 2005-10-21 S Sale Machielse Bernardus N M

SVP, Operations

Officer
70,000 -92.3%
33.41
US$2,339,036 		70,000 -92.3% 33.41 US$2,339,036
2005-03-04 2005-03-03 S Sale MACKLIN GORDON S Non-Executive Director
30,000 -75.0%
24.17
US$725,076 		30,000 -75.0% 24.17 US$725,076
2005-02-08 2005-02-07 PlS Planned sale CONNOR EDWARD M

EVP and Chief Medical Officer

Officer
100,000 -100.0%
24.31
US$2,431,290 		100,000 -100.0% 24.31 US$2,431,290
2004-08-03 2004-07-30 S Sale HACKMAN FRANKLIN BARBARA Non-Executive Director
40,000 -89.0%
23.07
US$922,836 		40,000 -89.0% 23.07 US$922,836
2004-05-06 2004-05-06 S Sale
MACKLIN GORDON S
105,000 -91.3%
24.26
US$2,547,436 		105,000 -91.3% 24.26 US$2,547,436
2004-04-30 2004-04-28 S Sale BOOTH MELVIN D Non-Executive Director
431,820 -99.5%
25.71
US$11,101,401 		431,820 -99.5% 25.71 US$11,101,401
2004-04-30 2004-04-28 S Sale BOOTH MELVIN D Non-Executive Director
18,180 -89.7%
25.60
US$465,408 		18,180 -89.7% 25.60 US$465,408
2004-02-06 2004-02-05 PlS Planned sale CONNOR EDWARD M

SVP Clinical Development
69,996 -100.0%
24.59
US$1,721,293 		69,996 -100.0% 24.59 US$1,721,293
Explore more

More insider trading research around Medimmune LLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America